SentinelOne faces slowing growth, margin pressure, and rising competition, limiting near-term upside potential. Find out why ...

Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...

New risks have emerged as well, including loan loss disclosures by two banks that rattled stock markets, and renewed ...